KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemed (CHE) Operating Leases (2019 - 2025)

Chemed (CHE) has 6 years of Operating Leases data on record, last reported at $99.5 million in Q3 2025.

  • For Q3 2025, Operating Leases fell 5.65% year-over-year to $99.5 million; the TTM value through Sep 2025 reached $99.5 million, down 5.65%, while the annual FY2024 figure was $98.5 million, 2.22% down from the prior year.
  • Operating Leases reached $99.5 million in Q3 2025 per CHE's latest filing, down from $102.1 million in the prior quarter.
  • Across five years, Operating Leases topped out at $110.5 million in Q4 2022 and bottomed at $98.5 million in Q4 2024.
  • Average Operating Leases over 4 years is $103.6 million, with a median of $103.7 million recorded in 2024.
  • Peak YoY movement for Operating Leases: decreased 8.81% in 2023, then decreased 2.22% in 2024.
  • A 4-year view of Operating Leases shows it stood at $110.5 million in 2022, then dropped by 8.81% to $100.8 million in 2023, then fell by 2.22% to $98.5 million in 2024, then grew by 0.94% to $99.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Leases were $99.5 million in Q3 2025, $102.1 million in Q1 2025, and $98.5 million in Q4 2024.